← Eichor
Study identifier: NCT04278651 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Early Antenatal Support for Iron Deficiency Anemia

Condition: Pregnancy Related · Anemia, Iron Deficiency · Anemia of Pregnancy  ·  Sponsor: Thomas Jefferson University

PhasePhase 4
Planned participants80
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.

This description comes directly from the study's public registry record.

Talk to the study team

Rupsa C Boelig, MD  ·  215-955-9196  ·  rupsa.boelig@jefferson.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Thomas Jefferson University HospitalPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04278651